Canadian Partnership AgainstCancer

What Canadian Partnership AgainstCancer does

The Canadian Partnership Against Cancer (the Partnership) is an independent, federally funded non-profit organization established in 2007 and headquartered in Toronto. It was created by Health Canada to coordinate and accelerate cancer control across Canada, working with provincial and territorial cancer agencies, federal/provincial/territorial governments, clinicians, researchers, patient organizations, and Indigenous communities to implement the Canadian Strategy for Cancer Control.

Its core portfolio comprises national coordination programs, data and analytics assets, and policy/research tools. Flagship products include OncoSim, a microsimulation modelling tool that projects cancer burden and evaluates screening and prevention scenarios; the Prevention Policies Directory, which maps evidence-based policies across jurisdictions; and PrePARE, an evidence platform supporting community-based prevention. Under the 2022–2027 strategy, the Partnership is advancing the Pan-Canadian Cancer Data Strategy and a Reconciliation Journey Strategic Action Plan co-developed with First Nations, Inuit and Métis communities.

The business model is non-commercial: the Partnership is funded by Health Canada through multi-year mandates (first mandate 2007–2012: CAD $250M; second mandate 2012–2017: CAD $241M) and, as of March 2016, ongoing/permanent federal appropriations. Revenue is grant-driven rather than transactional, with no product pricing or sales motion — value is delivered via convening, knowledge products, and analytical tools consumed by public-sector and partner stakeholders.

Name

Canadian Partnership AgainstCancer

Legal name

Canadian Partnership Against Cancer Corporation

Website

https://partnershipagainstcancer.ca

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

The Canadian Partnership Against Cancer is a federally funded, Toronto-based non-profit that coordinates cancer control across Canada — working with provinces, territories, and Indigenous communities to deliver national strategies, data assets, and tools such as OncoSim.

Ownership category

akta.pro rank

Product category

Cancer Control Coordination Services

NAICS

Business, Professional, Labor, Political, and Similar Organizations (8139), Social Advocacy Organizations (8133), Social Assistance (624)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-Membership Organizations (8600)

akta.pro primary industry

Public Health Governance, Interagency Coordination & Partnerships (HLAJAMAD)

akta.pro secondary industries

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Data, Surveillance & Digital Public Goods Partnerships for Global Health (HLAJAOAN)

Keywords

• Cancer control coordination
• Cancer simulation modeling
• Prevention policy directory
• Pan-canadian cancer data
• Health system partnerships

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Government Funding: The Partnership is funded by the federal government through Health Canada via contribution agreements. First mandate (2007-12) totaled $250 million; second mandate (2012-17) totaled $241 million. In March 2016, the federal government announced ongoing/permanent funding for the Partnership.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

The Canadian Partnership Against Cancer convenes cancer agencies, clinicians, federal bodies, and First Nations, Inuit and Métis organizations to implement the Canadian Strategy for Cancer Control across Canada. It delivers this through knowledge products and digital tools such as OncoSim (a cancer simulation model), the Prevention Policies Directory, PrePARE, screening-quality data reports, and online collaborative communities. Its core activity is national coordination, data modernization, and funded program implementation across the cancer control continuum from prevention to palliative care.

Product overview

The Canadian Partnership Against Cancer (CPAC) operates as a coordination and knowledge-management organization — not a single-product company — that offers a portfolio of tools, programs, data resources, and collaborative services organized around the Canadian Strategy for Cancer Control. Its product suite includes OncoSim (a cancer simulation modeling tool), the Prevention Policies Directory (a searchable policy database), PrePARE (a health promotion program), and multiple data report products including cervical cancer elimination data tables, breast and colorectal cancer screening quality indicator reports. The organization also provides collaborative community platforms, survivorship resources, models of care funding initiatives, and partner services that together form an interconnected ecosystem supporting cancer control from prevention through palliative care across Canada.

Differentiator

Problem solved

Functional benefit

Products and services

• OncoSim OncoSim is a cancer simulation and modeling tool that enables users to project outcomes and evaluate policy impacts across the cancer continuum. It supports scenario planning and analysis of cancer control interventions for researchers, policy makers, and public health authorities.
• Prevention Policies Directory An online directory cataloguing cancer prevention policies across Canadian jurisdictions, used to support evidence-based policy comparison and knowledge-sharing for public health practitioners and policy makers.
• PrePARE PrePARE is a health promotion program delivering resources and tools for cancer prevention and early detection, designed to inform public health action.
• Data Tables for Eliminating Cervical Cancer in Canada Digital Report Supplementary data tables supporting the digital report on eliminating cervical cancer in Canada, including modeling projections and surveillance data for public health stakeholders.
• Experiences of Cancer Patients in Transition Study A research initiative examining the experiences of cancer patients during transition phases of care, providing insights into patient journeys and system performance for clinicians, administrators, and policy makers.
• Survivorship Resources Information and support resources for cancer survivors addressing post-treatment needs, quality of life, and long-term health outcomes.
• Models of Care Funding Initiative A funding initiative supporting innovative models of cancer care delivery across Canadian jurisdictions, awarding resources to health system partners.
• Breast Cancer Screening Quality Indicators Data Tables Data tables for monitoring and evaluating breast cancer screening quality indicators across Canadian provinces and territories, supporting cancer agency performance measurement.

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core, primary and secondary.

• Canadian Partnership for Tomorrow's Health (CanPath)coreStrategic or Co-development PartnerRelated organization (Partenariat canadien pour la santé de demain) conducting population health research. Part of the Partnership's network of related cancer and health organizations in Canada.
• Canadian Cancer Research Alliance (CCRA)coreStrategic or Co-development PartnerAlliance of cancer research organizations working to accelerate cancer research in Canada. Collaborates with the Partnership on research coordination and knowledge sharing.
• Canadian Association of Provincial Cancer Agencies (CAPCA)coreStrategic or Co-development PartnerAssociation representing provincial cancer agencies. Key partner in implementing the Canadian Strategy for Cancer Control across Canada's provinces.
• Health CanadaprimaryOthersPrimary funder of the Partnership through ongoing contribution agreements. The Partnership is accountable to Health Canada and operates at arm's length from government.
• Provincial and Territorial Cancer ProgramscoreStrategic or Co-development PartnerCancer agencies and programs in each province and territory responsible for planning and delivering cancer care. Primary implementation partners for the Canadian Strategy for Cancer Control.
• First Nations, Inuit and Métis OrganizationscoreStrategic or Co-development PartnerIndigenous organizations including national organizations (Assembly of First Nations, Inuit Tapiriit Kanatami, Ralliement national des Métis), local and regional partners. Guided by the First Nations, Inuit and Métis action plan on cancer control.
• Canadian Cancer SocietycoreStrategic or Co-development PartnerMajor national cancer charity providing patient support and information. Represents patients and survivors on the Partnership's Board of Directors and contributes to performance measurement strategy.
• Public Health Agency of CanadacoreStrategic or Co-development PartnerFederal agency responsible for public health. Works with the Partnership on First Nations, Inuit and Métis health initiatives and cancer surveillance.
• First Nations and Inuit Health BranchcoreStrategic or Co-development PartnerFederal health branch working with Indigenous communities. Collaborates on improving cancer control for First Nations and Inuit populations.
• National Health OrganizationssecondaryStrategic or Co-development PartnerVarious national health organizations contributing expertise and resources to cancer control efforts coordinated by the Partnership.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Regional players

• European Cancer Organisation: Umbrella federation of European oncology societies and patient groups that convenes stakeholders across EU jurisdictions to reduce cancer burden and improve care. Structurally similar to CPAC's convening role, but operates across multiple countries rather than a single federated health system.

Direct peers

• National Comprehensive Cancer Network (NCCN): An alliance of leading US cancer centers that develops clinical practice guidelines, conducts outcomes research, and convenes stakeholders around cancer care quality. Comparable to CPAC in convening function and guideline/quality-indicator work (e.g., breast and colorectal screening indicators CPAC publishes).
• Cancer Australia: An Australian Government agency providing national leadership in cancer control across prevention, early detection, treatment, and care — directly comparable to CPAC's mandate. Operates with a similar model of convening stakeholders, funding initiatives, and providing evidence-based guidance to a federated health system.
• Canadian Agency for Drugs and Technologies in Health (CADTH): A federally funded Canadian organization that provides evidence-based drug and health technology assessments to coordinate decisions across federal, provincial, and territorial health systems. Closely parallels CPAC's evidence-synthesis, data, and interjurisdictional coordination mandate within Canadian healthcare.

Emerging players

• Movember Foundation: A leading global men's health charity funding prostate and testicular cancer research and programs. Operates in Canada and shares cancer awareness and fundraising dimensions, but is narrower in scope and lacks CPAC's national coordinating/government mandate.

Broad incumbents

• International Agency for Research on Cancer (IARC/WHO): WHO's specialized cancer agency that coordinates international cancer research, surveillance, and policy guidance. Comparable to CPAC in surveillance and data roles (Global Cancer Observatory parallels the Pan-Canadian Cancer Data Strategy) but at a global rather than national scale.
• National Cancer Institute (NCI): The US federal government's principal agency for cancer research, training, and coordination. While much larger and more research-funding focused than CPAC, NCI performs the analogous national cancer stewardship function — coordinating researchers, clinicians, and federal/state programs across a complex federal health system, making it the closest international analog to CPAC's convening role.
• Cancer Research UK: The world's largest independent cancer charity, funding research, influencing policy, and providing information across the UK cancer landscape. While charity-funded rather than government-funded, it shares CPAC's national coordination, research-prioritization, and policy-influence mandates.
• Canadian Cancer Society: Canada's largest national cancer charity, a core CPAC partner that provides patient support, information services, and advocacy. Not a coordinating body itself, but is one of CPAC's most strategic implementation partners and shares national scope across the cancer continuum.
• Public Health Agency of Canada: Canada's federal public health agency, which works alongside CPAC on cancer surveillance and Indigenous health initiatives. While much broader in scope (not cancer-specific), it is one of CPAC's closest federal partners and operates a similar national convening function for public health.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CancerStratCA
• YouTubeyoutube.com/c/CanadianPartnershipAgainstCancer
• Facebookfacebook.com/CanadianPartnershipAgainstCancer
• LinkedInlinkedin.com/company/canadian-partnership-against-cancer
• Instagraminstagram.com/cancerstratca

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Partnership AgainstCancer